HALOZYME THERAPEUTICS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Halozyme Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $137M, a 67.4% increase year-over-year.
  • Halozyme Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $392M, a 54.6% increase year-over-year.
  • Halozyme Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $282M, a 39.3% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $202M, a 49.8% decline from 2021.
  • Halozyme Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $403M, a 212% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $282M +$79.5M +39.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $202M -$201M -49.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $403M +$274M +212% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $129M +$201M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 -$72.2M +$8.09M +10.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 -$80.3M -$143M -228% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $63M +$166M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 -$103M -$70.8M -220% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-21
2015 -$32.2M +$36.1M +52.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
2014 -$68.4M +$15.1M +18.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$83.5M -$29.9M -55.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 -$53.6M -$33.8M -171% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 -$19.8M +$33.5M +62.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 -$53.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.